Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sabrina Maheo"'
Autor:
Titouan Cazaubiel, Xavier Leleu, Aurore Perrot, Salomon Manier, Laure Buisson, Sabrina Maheo, Laura Do Souto Ferreira, Romain Lannes, Luka Pavageau, Cyrille Hulin, Jean-Pierre Marolleau, Laurent Voillat, Karim Belhadj, Marion Divoux, Borhane Slama, Sabine Brechignac, Margaret Macro, Anne-Marie Stoppa, Laurence Sanhes, Frédérique Orsini-Piocelle, Jean Fontan, Marie-Lorraine Chretien, Hélène Demarquette, Mohamad Mohty, Anais Schavgoulidze, Herve Avet-Loiseau, Jill Corre
Publikováno v:
BLOOD
BLOOD, 2022, 139 (17), pp.2666-2672. ⟨10.1182/blood.2021014968⟩
BLOOD, 2022, 139 (17), pp.2666-2672. ⟨10.1182/blood.2021014968⟩
Primary plasma cell leukemia (pPCL) is an aggressive form of multiple myeloma (MM) that has not benefited from recent therapeutic advances in the field. Because it is very rare and heterogeneous, it remains poorly understood at the molecular level. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46eb789f3e06de5523b448873750c1c8
https://hal-u-picardie.archives-ouvertes.fr/hal-03684088
https://hal-u-picardie.archives-ouvertes.fr/hal-03684088
Autor:
Philippe Moreau, Laurent Garderet, Bertrand Arnulf, Sabrina Maheo, Lotfi Benboubker, Mamoun Dib, Sabine Brechignac, Nelly Robillard, Mohamad Mohty, Margaret Macro, Brigitte Pegourie, Thierry Facon, Brigitte Kolb, Karim Belhadj, Nikhil C. Munshi, Bruno Royer, Olivier Decaux, Arnaud Jaccard, Valérie Lauwers-Cances, Marie-Lorraine Chretien, Anne-Marie Stoppa, Hervé Avet-Loiseau, Xavier Leleu, Kenneth C. Anderson, Jean-Richard Eveillard, Martin Moorhead, Chantal Doyen, Cecile Fohrer, Lionel Karlin, Jill Corre, Victoria Carlton, Paul G. Richardson, Malek Faham, Jean-Luc Harousseau, Michel Attal, Nathalie Meuleman, Thomas D. Willis, Aurore Perrot, Cyrille Hulin, Thomas Dejoie
Publikováno v:
Blood
Blood, American Society of Hematology, 2018, 132 (23), pp.2456-2464. ⟨10.1182/blood-2018-06-858613⟩
Blood, Vol. 132, no. 23, p. 2456-2464 (2018)
Blood, American Society of Hematology, 2018, 132 (23), pp.2456-2464. ⟨10.1182/blood-2018-06-858613⟩
Blood, Vol. 132, no. 23, p. 2456-2464 (2018)
IF 15.132 (2017); International audience; The introduction of novel agents has led to major improvements in clinical outcomes for patients with multiple myeloma. To shorten evaluation times for new treatments, health agencies are currently examining
Autor:
Stanislas Goriely, Marie-Véronique Joubert, Tobias Bald, Mark J. Smyth, Ludovic Martinet, Elena Morandi, Loïc Dupré, Laure Buisson, Nadège Carrié, Marianne Weulersse, Guillaume Gaud, Marie Le Moine, Thomas Gossye, Anne Dejean, Hervé Avet-Loiseau, Ashmitha Sundarrajan, Assia Asrir, Andrea C. Pichler, Michaël Pérès, Abdelhadi Saoudi, Alejandra Martinez, Julien Mazieres, Sahar Kassem, Elisa Brauns, Els Verhoeyen, Indrajit Das, Sabrina Maheo, Matthias Braun, Vera Pancaldi, Clara Maria Scarlata, Marine Cuisinier, Maha Ayyoub, Laura Do Souto, Lea Lemaitre, Arantxa Agesta, Camille Guillerey
Publikováno v:
Immunity, 53 (4
Immunity
Immunity, Elsevier, 2020, 53 (4), pp.824-839.e10. ⟨10.1016/j.immuni.2020.09.006⟩
Immunity, 2020, 53 (4), pp.824-839.e10. ⟨10.1016/j.immuni.2020.09.006⟩
Immunity
Immunity, Elsevier, 2020, 53 (4), pp.824-839.e10. ⟨10.1016/j.immuni.2020.09.006⟩
Immunity, 2020, 53 (4), pp.824-839.e10. ⟨10.1016/j.immuni.2020.09.006⟩
Through complementary approaches, involving cancer patients’ samples and relevant mouse tumor models, Weulersse et al. reveal that CD8 T cells in the tumor microenvironment lose expression of the activating receptor CD226 (DNAM-1) in a manner that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dfe5be6f45852b02f2ba60ac27610fa
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/316003
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/316003
Autor:
Cyrille Hulin, Aurore Perrot, Jill Corre, Laura Do Souto Ferreira, Hervé Avet-Loiseau, Laure Buisson, Titouan Cazaubiel, Sabrina Maheo, Romain Lannes
Publikováno v:
Blood. 136:48-49
Background: Primary plasma cell leukemia (pPCL) is a rare and aggressive form of multiple myeloma (MM) with an extremely poor prognosis and distinct biological and clinical features. Because of its low incidence and its heterogeneity, biological know
Autor:
Mehmet Kemal Samur, Hervé Avet-Loiseau, Mariateresa Fulciniti, Aurore Perrot, Nikhil C. Munshi, Jill Corre, Laure Buisson, Alice Cleynen, Michel Attal, Sabrina Maheo
Publikováno v:
Blood
Blood, American Society of Hematology, 2018, 132 (26), pp.2778-2780. ⟨10.1182/blood-2018-09-876433⟩
Blood, American Society of Hematology, 2018, 132 (26), pp.2778-2780. ⟨10.1182/blood-2018-09-876433⟩
To the editor: Multiple myeloma (MM) is characterized by a large diversity of genetic abnormalities.[1][1][⇓][2]-[3][3] They can be classified in 3 categories: copy number changes, mutations, and translocations involving mainly the IGH gene at 14q3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9023a4a03975ab44da14904f65a739eb
https://hal.archives-ouvertes.fr/hal-02068205
https://hal.archives-ouvertes.fr/hal-02068205
Autor:
Marie-Lorraine Chretien, Hervé Avet-Loiseau, Sabrina Maheo, Céline Mazzotti, Murielle Roussel, Laura Do Souto, Benjamin Hebraud, Salomon Manier, Laure Buisson, Cyrille Hulin, Aurore Perrot, Xavier Leleu, Michel Attal, Jill Corre
Publikováno v:
Blood Advances
Blood Advances, The American Society of Hematology, 2018, 2 (21), pp.2811-2813. ⟨10.1182/bloodadvances.2018025197⟩
Blood Advances, The American Society of Hematology, 2018, 2 (21), pp.2811-2813. ⟨10.1182/bloodadvances.2018025197⟩
Key Points There is no correlation between ctDNA and bone marrow for MRD by NGS using only immunoglobulin gene rearrangements in myeloma patients.
Autor:
Kenneth C. Anderson, Jianbiao Zheng, Paul G. Richardson, Nikhil C. Munshi, Michel Attal, Sabrina Maheo, Malek Faham, Jill Corre, Hervé Avet-Loiseau
Publikováno v:
ResearcherID
Background: Recent reports support the prognostic importance of minimal residual disease (MRD) levels in multiple myeloma (MM) patients and suggest that novel methods for MRD assessment can play a role in the evolving MM treatment paradigm (Martinez-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8df55608f48c1929bc485544476b78d1
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000349243504210&KeyUID=WOS:000349243504210
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000349243504210&KeyUID=WOS:000349243504210
Autor:
Olivier Martínez, Vincent Ecochard, Sabrina Mahéo, Grégori Gross, Pierre Bodin, Justin Teissié, Jean-Marc Escudier, Laurent Paquereau
Publikováno v:
PLoS ONE, Vol 6, Iss 10, p e25510 (2011)
(S(C5'), R(P)) α,β-D- Constrained Nucleic Acids (CNA) are dinucleotide building blocks that can feature either B-type torsional angle values or non-canonical values, depending on their 5'C and P absolute stereochemistry. These CNA are modified neit
Externí odkaz:
https://doaj.org/article/35213cd634ca4946b9a1bef5cf31a006